Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

EyewireTV January 6th, 2021 thumbnail

Introduction

Oyster Point Submits NDA for Investigational Nasal Spray for Signs and Symptoms of Dry Eye Disease thumbnail

Oyster Point Submits NDA for Investigational Nasal Spray for Signs and Symptoms of Dry Eye Disease

story 2 thumbnail

Ocular Therapeutix Submits Supplemental NDA for Dextenza for Ocular Itching Associated With Allergic Conjunctivitis

story 3 thumbnail

Eyenovia Submits NDA for Fixed Combination Mydriatic Agent MydCombi

story 4 thumbnail

Genentech Announces Results From Two Phase 3 Studies Evaluating Faricimab for DME


Previous EyewireTV Episodes